- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01376349
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
RATIONALE: Dehydroepiandrosterone (DHEA) may help relieve vaginal symptoms in female cancer survivors.
PURPOSE: This randomized phase III trial studies DHEA to see how well it works compared to placebo in treating postmenopausal cancer survivors with vaginal symptoms.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Goal:
- To determine the effectiveness of two doses of daily vaginal prasterone (dehydroepiandrosterone [DHEA]) versus placebo for alleviation of the most bothersome vaginal symptom (vaginal dryness or dyspareunia) over 12 weeks.
Exploratory Goals:
- To evaluate any toxicities arising from DHEA in this patient population. (Exploratory)
- To evaluate the impact of vaginal DHEA on negative sexual thoughts, sexual function and urologic symptoms. (Exploratory)
- To explore the role of psychologic (mood, stress), physical (demographics and treatment variables) and situational factors (partner variables and fatigue) as predictors of vaginal dryness and performance outcomes at baseline and at various endpoints throughout the study. (Exploratory)
- To explore the characteristics of vaginal atrophy and the relationship between vaginal atrophy and quality-of-life questionnaire responses and exposure to hormonal therapy (tamoxifen, exemestane, anastrozole, or letrozole). (Exploratory)
- To examine the effects of the use of open-label vaginal DHEA gel over 8 weeks in women completing the placebo gel arm of the randomized trial. (Exploratory)
Correlative Research Goals:
- To evaluate the impact of vaginal DHEA on maturation index and pH (select institutions).
- To evaluate the impact of vaginal DHEA on sex steroid concentrations (estradiol, free testosterone, estrone, and DHEA-S) and markers of bone turnover (osteocalcin and bone alkaline phosphatase). (Correlative)
- As part of ongoing research for NCCTG Cancer Control studies, we are banking blood products for future studies. (Correlative)
OUTLINE: This is a multicenter study. Patients are stratified according to current tamoxifen therapy (yes vs no), concurrent aromatase inhibitor use (anastrozole/letrozole vs exemestane vs none), hysterectomy (yes vs no), and cigarette smoking (current vs past vs never). Patients are randomized to 1 of 3 treatment arms, patients receive low dose vaginal DHEA, high dose vaginal DHEA or vaginal placebo gel.
Participants may complete the Profile of Mood States (POMS), the Perceived Stress Scale (PSS), the Fatigue: Vitality subscale of the SF-36, the Vaginal Symptom Quality Questionnaire, the DHEA Side Effect Questionnaire, the Female Sexual Function Index (FSFI), the Sexually Related Intrusive Thoughts - ITS, Impact of Treatment Scale, the Urogenital Atrophy Questionnaire, and the Subject Global Impression of Change at baseline and periodically during study.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Arizona
-
Scottsdale, Arizona, United States, 85259-5499
- Mayo Clinic Scottsdale
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- Aurora Presbyterian Hospital
-
Boulder, Colorado, United States, 80301-9019
- Boulder Community Hospital
-
Colorado Springs, Colorado, United States, 80933
- Penrose Cancer Center at Penrose Hospital
-
Denver, Colorado, United States, 80210
- Porter Adventist Hospital
-
Denver, Colorado, United States, 80220
- Rose Medical Center
-
Denver, Colorado, United States, 80218
- Presbyterian - St. Luke's Medical Center
-
Denver, Colorado, United States, 80204
- St. Anthony Central Hospital
-
Denver, Colorado, United States, 80218
- St. Joseph Hospital
-
Denver, Colorado, United States, 80222
- CCOP - Colorado Cancer Research Program
-
Englewood, Colorado, United States, 80110
- Swedish Medical Center
-
Fort Collins, Colorado, United States, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, United States, 80528
- Front Range Cancer Specialists
-
Greeley, Colorado, United States, 80631
- North Colorado Medical Center
-
Littleton, Colorado, United States, 80122
- Littleton Adventist Hospital
-
Lone Tree, Colorado, United States, 80124
- Sky Ridge Medical Center
-
Longmont, Colorado, United States, 80501
- Hope Cancer Care Center at Longmont United Hospital
-
Loveland, Colorado, United States, 80539
- McKee Medical Center
-
Parker, Colorado, United States, 80138
- Parker Adventist Hospital
-
Pueblo, Colorado, United States, 81004
- St. Mary - Corwin Regional Medical Center
-
Thornton, Colorado, United States, 80229
- North Suburban Medical Center
-
Wheat Ridge, Colorado, United States, 80033
- Exempla Lutheran Medical Center
-
-
Connecticut
-
Hartford, Connecticut, United States, 06105
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
-
-
Florida
-
Daytona Beach, Florida, United States, 32114
- Herbert D. Kerman Regional Oncology Center - Daytona Beach
-
Gainesville, Florida, United States, 32610-0232
- University of Florida Shands Cancer Center
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic - Jacksonville
-
-
Hawaii
-
'Aiea, Hawaii, United States, 96701
- Kapiolani Medical Center at Pali Momi
-
Honolulu, Hawaii, United States, 96813
- Cancer Research Center of Hawaii
-
Honolulu, Hawaii, United States, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, United States, 96813
- OnCare Hawaii, Incorporated - Lusitana
-
Honolulu, Hawaii, United States, 96813
- Queen's Cancer Institute at Queen's Medical Center
-
Honolulu, Hawaii, United States, 96813
- Straub Clinic and Hospital, Incorporated
-
Honolulu, Hawaii, United States, 96817
- Hawaii Medical Center - East
-
Honolulu, Hawaii, United States, 96817
- OnCare Hawaii, Incorporated - Kuakini
-
Kailua, Hawaii, United States, 96734
- Castle Medical Center
-
Lihue, Hawaii, United States, 96766
- Kauai Medical Clinic
-
Wailuku, Hawaii, United States, 96793
- Maui Memorial Medical Center
-
Wailuku, Hawaii, United States, 96793
- Pacific Cancer Institute - Maui
-
-
Idaho
-
Boise, Idaho, United States, 83706
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
-
Meridian, Idaho, United States, 83642
- Idaho Urologic Institute, PA
-
-
Illinois
-
Bloomington, Illinois, United States, 61701
- Illinois CancerCare - Bloomington
-
Bloomington, Illinois, United States, 61701
- St. Joseph Medical Center
-
Canton, Illinois, United States, 61520
- Illinois CancerCare - Canton
-
Carthage, Illinois, United States, 62321
- Illinois CancerCare - Carthage
-
Eureka, Illinois, United States, 61530
- Illinois CancerCare - Eureka
-
Eureka, Illinois, United States, 61530
- Eureka Community Hospital
-
Galesburg, Illinois, United States, 61401
- Galesburg Clinic, PC
-
Havana, Illinois, United States, 62644
- Illinois CancerCare - Havana
-
Kewanee, Illinois, United States, 61443
- Illinois CancerCare - Kewanee Clinic
-
Macomb, Illinois, United States, 61455
- Illinois CancerCare - Macomb
-
Moline, Illinois, United States, 61265
-
Moline, Illinois, United States, 61265
- Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
-
Monmouth, Illinois, United States, 61462
- Illinois CancerCare - Monmouth
-
Monmouth, Illinois, United States, 61462
- OSF Holy Family Medical Center
-
Normal, Illinois, United States, 61761
- Bromenn Regional Medical Center
-
Normal, Illinois, United States, 61761
- Community Cancer Center
-
Normal, Illinois, United States, 61761
- Illinois CancerCare - Community Cancer Center
-
Ottawa, Illinois, United States, 61350
- Community Hospital of Ottawa
-
Ottawa, Illinois, United States, 61350
- Oncology Hematology Associates of Central Illinois, PC - Ottawa
-
Pekin, Illinois, United States, 61554
- Cancer Treatment Center at Pekin Hospital
-
Pekin, Illinois, United States, 61603
- Illinois CancerCare - Pekin
-
Peoria, Illinois, United States, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, United States, 61614
- Proctor Hospital
-
Peoria, Illinois, United States, 61637
- OSF St. Francis Medical Center
-
Peoria, Illinois, United States, 61615
- CCOP - Illinois Oncology Research Association
-
Peoria, Illinois, United States, 61615
- Oncology Hematology Associates of Central Illinois, PC - Peoria
-
Peru, Illinois, United States, 61354
- Illinois CancerCare - Peru
-
Peru, Illinois, United States, 61354
- Illinois Valley Community Hospital
-
Princeton, Illinois, United States, 61356
- Illinois CancerCare - Princeton
-
Spring Valley, Illinois, United States, 61362
- Illinois CancerCare - Spring Valley
-
Urbana, Illinois, United States, 61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
Elkhart, Indiana, United States, 46515
- Elkhart General Hospital
-
Elkhart, Indiana, United States, 46514-2098
- Elkhart Clinic, LLC
-
Elkhart, Indiana, United States, 46514
- Michiana Hematology-Oncology, PC - Elkhart
-
Indianapolis, Indiana, United States, 46237
- St. Francis Hospital Cancer Care Services
-
Kokomo, Indiana, United States, 46904
- Howard Community Hospital
-
La Porte, Indiana, United States, 46350
- Center for Cancer Therapy at LaPorte Hospital and Health Services
-
Michigan City, Indiana, United States, 46360
- Saint Anthony Memorial Health Centers
-
Mishawaka, Indiana, United States, 46545-1470
- Michiana Hematology-Oncology, PC - South Bend
-
Mishawaka, Indiana, United States, 46545-1470
- Saint Joseph Regional Medical Center
-
Plymouth, Indiana, United States, 46563
- Michiana Hematology Oncology PC - Plymouth
-
Richmond, Indiana, United States, 47374
- Reid Hospital & Health Care Services
-
South Bend, Indiana, United States, 46601
- Memorial Hospital of South Bend
-
South Bend, Indiana, United States, 46601
- CCOP - Northern Indiana CR Consortium
-
Westville, Indiana, United States, 46391
- Michiana Hematology Oncology PC - La Porte
-
-
Iowa
-
Bettendorf, Iowa, United States, 52722
-
Cedar Rapids, Iowa, United States, 52403
- Cedar Rapids Oncology Associates
-
Cedar Rapids, Iowa, United States, 52403
- Mercy Regional Cancer Center at Mercy Medical Center
-
Clive, Iowa, United States, 50325
- Medical Oncology and Hematology Associates - West Des Moines
-
Clive, Iowa, United States, 50325
- Mercy Cancer Center - West Lakes
-
Des Moines, Iowa, United States, 50309
- CCOP - Iowa Oncology Research Association
-
Des Moines, Iowa, United States, 50309
- John Stoddard Cancer Center at Iowa Methodist Medical Center
-
Des Moines, Iowa, United States, 50309
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
-
Des Moines, Iowa, United States, 50314
- Medical Oncology and Hematology Associates at Mercy Cancer Center
-
Des Moines, Iowa, United States, 50314
- Mercy Cancer Center at Mercy Medical Center - Des Moines
-
Des Moines, Iowa, United States, 50316
- John Stoddard Cancer Center at Iowa Lutheran Hospital
-
Sioux City, Iowa, United States, 51101
- Siouxland Hematology-Oncology Associates, LLP
-
Sioux City, Iowa, United States, 51102
- Mercy Medical Center - Sioux City
-
Sioux City, Iowa, United States, 51104
- St. Luke's Regional Medical Center
-
West Des Moines, Iowa, United States, 50266-7700
- Methodist West Hospital
-
-
Kansas
-
Chanute, Kansas, United States, 66720
- Cancer Center of Kansas, PA - Chanute
-
Dodge City, Kansas, United States, 67801
- Cancer Center of Kansas, PA - Dodge City
-
El Dorado, Kansas, United States, 67042
- Cancer Center of Kansas, PA - El Dorado
-
Fort Scott, Kansas, United States, 66701
- Cancer Center of Kansas - Fort Scott
-
Independence, Kansas, United States, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, United States, 67068
- Cancer Center of Kansas, PA - Kingman
-
Lawrence, Kansas, United States, 66044
- Lawrence Memorial Hospital
-
Liberal, Kansas, United States, 67901
- Cancer Center of Kansas, PA - Liberal
-
McPherson, Kansas, United States, 67460
- Cancer Center of Kansas, PA - McPherson
-
Newton, Kansas, United States, 67114
- Cancer Center of Kansas, PA - Newton
-
Parsons, Kansas, United States, 67357
- Cancer Center of Kansas, PA - Parsons
-
Pratt, Kansas, United States, 67124
- Cancer Center of Kansas, PA - Pratt
-
Salina, Kansas, United States, 67401
- Cancer Center of Kansas, PA - Salina
-
Wellington, Kansas, United States, 67152
- Cancer Center of Kansas, PA - Wellington
-
Wichita, Kansas, United States, 67208
- Cancer Center of Kansas, PA - Medical Arts Tower
-
Wichita, Kansas, United States, 67214
- Cancer Center of Kansas, PA - Wichita
-
Wichita, Kansas, United States, 67214
- CCOP - Wichita
-
Wichita, Kansas, United States, 67214
- Via Christi Cancer Center at Via Christi Regional Medical Center
-
Wichita, Kansas, United States, 67208
- Associates in Womens Health, PA - North Review
-
Winfield, Kansas, United States, 67156
- Cancer Center of Kansas, PA - Winfield
-
-
Michigan
-
Adrian, Michigan, United States, 49221
- Hickman Cancer Center at Bixby Medical Center
-
Ann Arbor, Michigan, United States, 48106-0995
- Saint Joseph Mercy Cancer Center
-
Ann Arbor, Michigan, United States, 48106
- CCOP - Michigan Cancer Research Consortium
-
Dearborn, Michigan, United States, 48123-2500
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
-
Escanaba, Michigan, United States, 49431
- Green Bay Oncology, Limited - Escanaba
-
Flint, Michigan, United States, 48503
- Hurley Medical Center
-
Flint, Michigan, United States, 48503
- Genesys Hurley Cancer Institute
-
Grand Blanc, Michigan, United States, 48439
- Genesys Regional Medical Center
-
Grosse Pointe Woods, Michigan, United States, 48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
Iron Mountain, Michigan, United States, 49801
- Dickinson County Healthcare System
-
Jackson, Michigan, United States, 49201
- Foote Memorial Hospital
-
Lansing, Michigan, United States, 48912-1811
- Sparrow Regional Cancer Center
-
Livonia, Michigan, United States, 48154
- St. Mary Mercy Hospital
-
Monroe, Michigan, United States, 48162
- Community Cancer Center of Monroe
-
Monroe, Michigan, United States, 48162
- Mercy Memorial Hospital - Monroe
-
Pontiac, Michigan, United States, 48341-2985
- St. Joseph Mercy Oakland
-
Port Huron, Michigan, United States, 48060
- Mercy Regional Cancer Center at Mercy Hospital
-
Saginaw, Michigan, United States, 48601
- Seton Cancer Institute at Saint Mary's - Saginaw
-
Saint Joseph, Michigan, United States, 49085
- Lakeside Cancer Specialists, PLLC
-
Saint Joseph, Michigan, United States, 49085
- Lakeland Regional Cancer Care Center - St. Joseph
-
Warren, Michigan, United States, 48093
- St. John Macomb Hospital
-
-
Minnesota
-
Bemidji, Minnesota, United States, 56601
- MeritCare Bemidji
-
Brainerd, Minnesota, United States, 56401
- St. Joseph's Medical Center
-
Burnsville, Minnesota, United States, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, United States, 55433
- Mercy and Unity Cancer Center at Mercy Hospital
-
Duluth, Minnesota, United States, 55805
- CCOP - Duluth
-
Duluth, Minnesota, United States, 55805
- Miller - Dwan Medical Center
-
Duluth, Minnesota, United States, 55805-1983
- Essentia Health - Duluth Clinic
-
Edina, Minnesota, United States, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, United States, 55432
- Mercy and Unity Cancer Center at Unity Hospital
-
Hutchinson, Minnesota, United States, 55350
- Hutchinson Area Health Care
-
Mankato, Minnesota, United States, 56002
- Immanuel St. Joseph's
-
Maplewood, Minnesota, United States, 55109
- HealthEast Cancer Care at St. John's Hospital
-
Maplewood, Minnesota, United States, 55109
- Minnesota Oncology - Maplewood
-
Minneapolis, Minnesota, United States, 55407
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center - Minneapolis
-
New Ulm, Minnesota, United States, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, United States, 55422-2900
- Humphrey Cancer Center at North Memorial Outpatient Center
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic Cancer Center
-
Saint Cloud, Minnesota, United States, 56303
- CentraCare Clinic - River Campus
-
Saint Cloud, Minnesota, United States, 56303
- Coborn Cancer Center
-
Saint Louis Park, Minnesota, United States, 55416
- CCOP - Metro-Minnesota
-
Saint Louis Park, Minnesota, United States, 55416
- Park Nicollet Cancer Center
-
Saint Paul, Minnesota, United States, 55102
- United Hospital
-
Saint Paul, Minnesota, United States, 55101
- Regions Hospital Cancer Care Center
-
Shakopee, Minnesota, United States, 55379
- St. Francis Cancer Center at St. Francis Medical Center
-
Stillwater, Minnesota, United States, 55082
- Lakeview Hospital
-
Waconia, Minnesota, United States, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, United States, 56201
- Willmar Cancer Center at Rice Memorial Hospital
-
Woodbury, Minnesota, United States, 55125
- Minnesota Oncology - Woodbury
-
-
Missouri
-
Rolla, Missouri, United States, 65401
- Mercy Clinic Cancer and Hematology - Rolla
-
Springfield, Missouri, United States, 65804
- St. John's Regional Health Center
-
Springfield, Missouri, United States, 65807
- Hulston Cancer Center at Cox Medical Center South
-
Springfield, Missouri, United States, 65804
- CCOP - Cancer Research for the Ozarks
-
-
Montana
-
Billings, Montana, United States, 59101
- CCOP - Montana Cancer Consortium
-
Billings, Montana, United States, 59101
- St. Vincent Healthcare Cancer Care Services
-
Billings, Montana, United States, 59107-7000
- Billings Clinic - Downtown
-
Billings, Montana, United States, 59102
- Hematology-Oncology Centers of the Northern Rockies - Billings
-
Bozeman, Montana, United States, 59715
- Bozeman Deaconess Cancer Center
-
Butte, Montana, United States, 59701
- St. James Healthcare Cancer Care
-
Great Falls, Montana, United States, 59405
- Benefis Sletten Cancer Institute
-
Helena, Montana, United States, 59601
- St. Peter's Hospital
-
Kalispell, Montana, United States, 59901
- Kalispell Regional Medical Center
-
Missoula, Montana, United States, 59807-7877
- Montana Cancer Specialists at Montana Cancer Center
-
Missoula, Montana, United States, 59807
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68510
- Cancer Resource Center - Lincoln
-
Omaha, Nebraska, United States, 68106
- CCOP - Missouri Valley Cancer Consortium
-
Omaha, Nebraska, United States, 68122
- Immanuel Medical Center
-
Omaha, Nebraska, United States, 68124
- Alegant Health Cancer Center at Bergan Mercy Medical Center
-
Omaha, Nebraska, United States, 68131-2197
- Creighton University Medical Center
-
Omaha, Nebraska, United States, 68130
- Lakeside Hospital
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131-5636
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, United States, 87102
- Lovelace Medical Center - Downtown
-
Albuquerque, New Mexico, United States, 87110
- Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
-
Las Cruces, New Mexico, United States, 88011
- University of New Mexico Cancer Center - South
-
-
North Carolina
-
Rutherfordton, North Carolina, United States, 28139
- Rutherford Hospital
-
-
North Dakota
-
Fargo, North Dakota, United States, 58122
- CCOP - MeritCare Hospital
-
Fargo, North Dakota, United States, 58102
- MeritCare Broadway
-
Fargo, North Dakota, United States, 58103
- Dakota Cancer Institute at Dakota Clinic - South University
-
Grand Forks, North Dakota, United States, 58201
- Altru Cancer Center at Altru Hospital
-
-
Ohio
-
Bowling Green, Ohio, United States, 43402
- Wood County Oncology Center
-
Chillicothe, Ohio, United States, 45601
- Adena Regional Medical Center
-
Columbus, Ohio, United States, 43214-3998
- Riverside Methodist Hospital Cancer Care
-
Columbus, Ohio, United States, 43222
- Mount Carmel Health - West Hospital
-
Columbus, Ohio, United States, 43215
- CCOP - Columbus
-
Columbus, Ohio, United States, 43215
- Grant Medical Center Cancer Care
-
Columbus, Ohio, United States, 43228
- Doctors Hospital at Ohio Health
-
Columbus, Ohio, United States, 43219
- Zangmeister Center
-
Dayton, Ohio, United States, 45405
- Grandview Hospital
-
Dayton, Ohio, United States, 45406
- Good Samaritan Hospital
-
Dayton, Ohio, United States, 45409
- David L. Rike Cancer Center at Miami Valley Hospital
-
Dayton, Ohio, United States, 45415
- Samaritan North Cancer Care Center
-
Dayton, Ohio, United States, 45420
- CCOP - Dayton
-
Delaware, Ohio, United States, 43015
- Grady Memorial Hospital
-
Elyria, Ohio, United States, 44035
- Community Cancer Center
-
Elyria, Ohio, United States, 44035
- Hematology Oncology Center
-
Findlay, Ohio, United States, 45840
- Blanchard Valley Medical Associates
-
Franklin, Ohio, United States, 45005-1066
- Middletown Regional Hospital
-
Greenville, Ohio, United States, 45331
- Wayne Hospital
-
Kettering, Ohio, United States, 45429
- Charles F. Kettering Memorial Hospital
-
Lancaster, Ohio, United States, 43130
- Fairfield Medical Center
-
Lima, Ohio, United States, 45804
- Lima Memorial Hospital
-
Marietta, Ohio, United States, 45750
- Strecker Cancer Center at Marietta Memorial Hospital
-
Maumee, Ohio, United States, 43537-1839
- Northwest Ohio Oncology Center
-
Mount Vernon, Ohio, United States, 43050
- Knox Community Hospital
-
Newark, Ohio, United States, 43055
- Licking Memorial Cancer Care Program at Licking Memorial Hospital
-
Oregon, Ohio, United States, 43616
- St. Charles Mercy Hospital
-
Oregon, Ohio, United States, 43616
- Toledo Clinic - Oregon
-
Portsmouth, Ohio, United States, 45662
- Southern Ohio Medical Center Cancer Center
-
Springfield, Ohio, United States, 45505
- Community Hospital of Springfield and Clark County
-
Sylvania, Ohio, United States, 43560
- Flower Hospital Cancer Center
-
Tiffin, Ohio, United States, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, United States, 43608
- St. Vincent Mercy Medical Center
-
Toledo, Ohio, United States, 43606
- Toledo Hospital
-
Toledo, Ohio, United States, 43614
- Medical University of Ohio Cancer Center
-
Toledo, Ohio, United States, 43617
- CCOP - Toledo Community Hospital
-
Toledo, Ohio, United States, 43623
- Toledo Clinic, Incorporated - Main Clinic
-
Toledo, Ohio, United States, 43623
- St. Anne Mercy Hospital
-
Troy, Ohio, United States, 45373-1300
- UVMC Cancer Care Center at Upper Valley Medical Center
-
Wauseon, Ohio, United States, 43567
- Fulton County Health Center
-
Westerville, Ohio, United States, 43081
- Mount Carmel St. Ann's Cancer Center
-
Wright-Patterson Air Force Base, Ohio, United States, 45433-5529
- United States Air Force Medical Center - Wright-Patterson
-
Xenia, Ohio, United States, 45385
- Ruth G. McMillan Cancer Center at Greene Memorial Hospital
-
Zanesville, Ohio, United States, 43701
- Genesis - Good Samaritan Hospital
-
-
Oregon
-
Clackamas, Oregon, United States, 97015
- Clackamas Radiation Oncology Center
-
Milwaukie, Oregon, United States, 97222
- Providence Milwaukie Hospital
-
Newberg, Oregon, United States, 97132
- Providence Newberg Medical Center
-
Oregon City, Oregon, United States, 97045
- Willamette Falls Hospital
-
Portland, Oregon, United States, 97213-2967
- Providence Cancer Center at Providence Portland Medical Center
-
Portland, Oregon, United States, 97225
- CCOP - Columbia River Oncology Program
-
Portland, Oregon, United States, 97225
- Providence St. Vincent Medical Center
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18105
- Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
-
Bethlehem, Pennsylvania, United States, 18017
- Lehigh Valley Hospital - Muhlenberg
-
Danville, Pennsylvania, United States, 17822-0001
- Geisinger Cancer Institute at Geisinger Health
-
Hazleton, Pennsylvania, United States, 18201
- Geisinger Hazleton Cancer Center
-
State College, Pennsylvania, United States, 16801
- Geisinger Medical Group - Scenery Park
-
Wilkes-Barre, Pennsylvania, United States, 18711
- Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
-
-
South Carolina
-
Anderson, South Carolina, United States, 29621
- AnMed Cancer Center
-
Greenville, South Carolina, United States, 29601
- Bon Secours St. Francis Health System
-
Lancaster, South Carolina, United States, 29720
- Carolina Blood and Cancer Care Associates, PA
-
Rock Hill, South Carolina, United States, 29732
- Carolina Blood and Cancer Care
-
Spartanburg, South Carolina, United States, 29303
- CCOP - Upstate Carolina
-
Spartanburg, South Carolina, United States, 29303
- Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, United States, 57117-5039
- Sanford Cancer Center at Sanford USD Medical Center
-
-
Virginia
-
Fredericksburg, Virginia, United States, 22401
- Fredericksburg Oncology, Incorporated
-
-
Washington
-
Vancouver, Washington, United States, 98684
- Northwest Cancer Specialists at Vancouver Cancer Center
-
Vancouver, Washington, United States, 98664
- Southwest Washington Medical Center Cancer Center
-
-
Wisconsin
-
Green Bay, Wisconsin, United States, 54307-3508
- St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, United States, 54301-3526
- Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, United States, 54303
- Green Bay Oncology, Limited at St. Mary's Hospital
-
Green Bay, Wisconsin, United States, 54303
- St. Mary's Hospital Medical Center - Green Bay
-
La Crosse, Wisconsin, United States, 54601
- Franciscan Skemp Healthcare - La Crosse Campus
-
Manitowoc, Wisconsin, United States, 54221-1450
- Holy Family Memorial Medical Center Cancer Care Center
-
Marinette, Wisconsin, United States, 54143
- Bay Area Cancer Care Center at Bay Area Medical Center
-
Oconto Falls, Wisconsin, United States, 54154
- Green Bay Oncology, Limited - Oconto Falls
-
Sheboygan, Wisconsin, United States, 53081
- St. Nicholas Hospital
-
Sturgeon Bay, Wisconsin, United States, 54235
- Green Bay Oncology, Limited - Sturgeon Bay
-
-
Wyoming
-
Casper, Wyoming, United States, 82609
- Rocky Mountain Oncology
-
Sheridan, Wyoming, United States, 82801
- Welch Cancer Center at Sheridan Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 18 years
Postmenopausal women with a history of breast or gynecologic cancer (currently no evidence of disease). Note: Postmenopausal status will be determined by the following criteria:
- 12 months without a period or bilateral oophorectomy or complete chemical ovarian suppression for the past 12 months with continued suppression planned throughout the course of the study
menopausal status will be determined by an FSH and an estradiol value in the postmenopausal range (generally FSH > 40IU/L and estradiol < 10 pg/ml, depending on laboratory) if:
- 9 months without a period or
- post hysterectomy with at least one ovary remaining and less than 55 years old. Note: if age 55 or older with these criteria, then menopausal status does not need to be determined by labs
- Significant vaginal complaints. Note: Defined as persistent vaginal dryness and/or pain with intercourse (dyspareunia) of sufficient severity to make a patient desire therapeutic intervention.
- Eligibility questionnaire response must be moderate or worse levels of severity on one of the two symptoms, either dryness or dyspareunia. The protocol contains more information.
- Vaginal symptoms must have been present ≥ 2 months prior to randomization.
- Life expectancy > 12 months.
- Ability to complete questionnaires by themselves or with assistance.
- Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1.
- The patient must provide informed written consent.
- Willing to return to the enrolling institution for follow-up.
- Willing to provide blood samples for correlative research purposes.
Exclusion Criteria:
- Initiation or discontinuation of tamoxifen or aromatase inhibitors ≤ 2 months prior to randomization or plans to initiate or discontinue any of these medications during the 12-week study.
- Current diagnosis of an active vaginal infection, if symptoms of vaginal infection, this must be ruled out (ie, foul discharge, fever).
- Concurrent chemotherapy (long term adjuvant herceptin, lapatanib, and/or bevacizumab is allowed.
- Planned use of any vaginal preparations during the study period (including any over the counter or herbal preparations). Note: Water-based lubricants (such as KY jelly) are allowed during sexual intercourse.
Use of any daily non-hormonal vaginal preparations ≤ 1 week prior to study entry.
Exception: Daily water-based lubricants for sexual intercourse. Note: Patients who stop agent may be enrolled after one week.
- Current (≤ 4 weeks prior to randomization), or planned during the study period, use of any estrogen product or any kind of hormonal vaginal product including bioidentical hormones, estriol or any androgen product.
- Use of pharmacologic soy or phytoestrogen preparations (Dietary intake of soy - ie milk is acceptable).
- On a placebo controlled trial for endocrine therapy.
- Prior or concurrent pelvic radiation therapy.
- Prior radical pelvic surgery, specifically vaginectomy or pelvic exenteration (TAH/BSO) is allowed).
Diagnosis of any of the following conditions within the past five years:
- Essential vulvodynia
- Vulvar vestibulitis
- Bartholin cyst/abscess
- History of Bartholin gland surgery
- Lichen sclerosis
- Lichen planus of the vulvovaginal region
- Desquamative vaginitis
History or current diagnosis of any of the following conditions:
- Vulvar or vaginal dysplasia
- Vaginal prolapse
- Women of childbearing potential, premenopausal women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm I low dose DHEA
Participants apply a low dose (3.25 mg) of vaginal prasterone (dehydroepiandrosterone [DHEA]) gel once daily (QD), at bed time, for 12 weeks.
Treatment continues until unacceptable adverse events or patient refusal to continue participation on the study.
|
Applied vaginally
|
|
Experimental: Arm II high dose DHEA
Participants apply a high dose (6.5 mg) of vaginal DHEA gel QD, at bed time, for 12 weeks.
Treatment continues until unacceptable adverse events or patient refusal to continue participation on the study.
|
Applied vaginally
|
|
Placebo Comparator: Arm III placebo
Participants apply a vaginal placebo gel QD, at bed time, for 12 weeks.
There is an Optional Continuation Phase (for placebo arm only): Participants apply a high dose of vaginal DHEA gel QD, at bed time, for 12 weeks.
Treatment continues until unacceptable adverse events or patient refusal to continue participation on the study.
|
Applied vaginally
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alleviation of the Most Bothersome Vaginal Symptom (Vaginal Dryness or Dyspareunia) Over 12 Weeks
Time Frame: At baseline and 12 weeks
|
The primary outcome is severity of the most bothersome vaginal symptom: dryness or dyspareunia.
The Vaginal Symptom Measure (VSM) was used to evaluate the severity of vaginal dryness and dyspareunia.
The VSM uses a 5- point ordinal response scale; 1="none", 2="mild", 3="moderate", 4="severe" and 5="very severe" to measure the severity associated with vaginal dryness and/or dyspareunia.
For each patient, the change in severity was calculated by subtracting the baseline from the week 12 reported score.
Therefore, the full range of scores ranges from -4 (greatest decrease in severity) to 4 (greatest increase in severity).
A negative score indicates a decrease in severity from baseline, zero indicates no reported affect and positive scores indicate a more severe report at week 12.
The primary assessment method will be a comparison of the averages of the changes over time in the severity items for the most bothersome symptom from baseline to 12 weeks (as indicated at baseline).
|
At baseline and 12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Debra Barton, RN, PhD, AOCN, FAAN, University of Michigan
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
- breast cancer
- depression
- endometrial cancer
- cancer survivor
- fallopian tube cancer
- anxiety disorder
- cognitive/functional effects
- ovarian epithelial cancer
- primary peritoneal cavity cancer
- sexual dysfunction
- cervical cancer
- ovarian sarcoma
- ovarian stromal cancer
- ovarian germ cell tumor
- uterine sarcoma
- vaginal cancer
- vulvar cancer
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCCTG-N10C1
- CDR0000702003 (Registry Identifier: PDQ (Physician Data Query))
- NCI-2011-02677 (Registry Identifier: CTRP (Clinical Trials Reporting System))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Case Comprehensive Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
Clinical Trials on prasterone
-
Universidad de GuanajuatoCompletedCardio Metabolic RiskMexico
-
European Institute of OncologyNot yet recruiting
-
EndoCeutics Inc.CompletedVaginal AtrophyUnited States, Canada
-
Genelabs TechnologiesCompletedSystemic Lupus ErythematosusUnited States, Mexico
-
EndoCeutics Inc.Completed
-
San Diego Sexual MedicineCompleted
-
Center for Vulvovaginal DisordersEndoCeutics Inc.UnknownMenopause | Vulvovaginal Atrophy | Dyspareunia | Genitourinary Syndrome of Menopause | Menopause SyndromeUnited States
-
EndoCeutics Inc.Completed
-
EndoCeutics Inc.Completed
-
CHU de Quebec-Universite LavalCompleted